Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-04-29, Stock:ABBV, The news for the past five days is as follows:
2021-04-22: NEWS1: Were Hedge Funds Right About AbbVie (ABBV)?.NEWS2: AbbVie Receives Health Canada Approval of HUMIRA® (adalimumab) for the Treatment of Pediatric Patients with Moderately to Severely Active Ulcerative Colitis.NEWS3: Is It Time To Buy AbbVie Stock As It Barrels Toward A New Buy Point?.
2021-04-23: NEWS1: Roche, AbbVie, Bristol-Myers Are Latest To Win European Medicines Agency's CHMP Positive Opinion.NEWS2: What's in the Cards for AbbVie (ABBV) This Earnings Season?.NEWS3: AbbVie Receives Positive CHMP Opinion for VENCLYXTO® (venetoclax) as a Combination Regimen for Adult Patients with Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy.
2021-04-26: NEWS1: AbbVie (ABBV) Gains But Lags Market: What You Should Know.
2021-04-27: NEWS1: Allergan, an AbbVie Company, to Share New Data Highlighting Latest Advancements in Eye Care at ARVO (Association for Research in Vision and Ophthalmology) 2021 Annual Virtual Meeting.
2021-04-28: NEWS1: Is AbbVie a Buy Before Its Earnings Report Friday?.NEWS2: Healthcare ETFs on Radar As Q1 Earnings Unfold.NEWS3: This is Why AbbVie (ABBV) is a Great Dividend Stock.NEWS4: Strong New Drugs Sales to Aid AbbVie's (ABBV) Q1 Earnings.

Answer: Decrease